Analysis of a New Biomarker for Prostate Cancer Diagnosis (HEM)

Corporacion Parc Tauli

Status: Unknown

Conditions: Patients With Suspected Prostate Cancer

Treatments: Other: determine the levels of the "HEM" substance in seminal plasma

Study type: Observational

Funder types: Other

Identifiers

NCT01819740

CSPT/URO/2013/PROSTATE

Details and patient eligibility

About

The aim of our study is to determine if the levels of the "HEM" substance in seminal plasma are associated with the presence of prostate cancer in transrectal prostate biopsy.

Enrollment: 28 estimated patients

Sex: Male

Ages: 45 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical or laboratory suspected of prostate cancer

Exclusion criteria

• Inability to ejaculate

Trial design

28 participants in 1 patient group

patients with suspected prostate cancer

Treatment:

Other: determine the levels of the "HEM" substance in seminal plasma